Cementless Total Knee Systems Market Size & Share 2026-2035

Cementless Total Knee Systems Market Size

The global cementless total knee systems market was estimated at USD 5.2 billion in 2025. The market is expected to grow from USD 5.5 billion in 2026 to USD 9.7 billion in 2035, at a CAGR of 6.5% during the forecast period, according to the latest report published by Global Market Insights Inc.

The market is driven by numerous factors, such as the rising prevalence of osteoarthritis and rheumatoid arthritis globally and increasing adoption of minimally invasive surgical techniques, among other factors.

The cementless total knee systems market refers to the market for knee implants that do not require bone cement for fixation. These systems rely on biological fixation, where the implant integrates with the bone through a porous surface or coating. This type of knee replacement offers advantages like reduced risk of loosening and better long-term performance compared to cemented systems.

The growing geriatric population prone to joint disorders is expected to fuel the industry's growth. ZIMMER BIOMET, Johnson & Johnson, Smith + Nephew, Medacta, and Stryker are among the leading players operating in the market. These players mainly focus on product innovation, geographic expansion, research and development, and collaboration with local or regional healthcare providers, among other factors.

The market has increased from USD 4.4 billion in 2022 and reached USD 4.9 billion in 2024, with a historic growth rate of 5.5%. The rising prevalence of osteoarthritis and rheumatoid arthritis globally significantly drove growth in the cementless total knee systems market, as degenerative and inflammatory joint conditions increasingly resulted in chronic pain, reduced mobility, and diminished quality of life. CDC 2024 data estimated that approximately 1 in 5 U.S. adults (53.2 million people) had some form of arthritis, with osteoarthritis affecting about 32.5 million adults, making it the most common form of the disease. This high disease burden translated into substantial societal and personal costs, including long‑term disability, productivity loss, and elevated healthcare utilization. As younger and more active patients sought durable surgical solutions with improved biological fixation and long implant lifespans, demand shifted toward cementless total knee systems, which were perceived to better support bone preservation and long‑term functional outcomes, thereby strengthening market adoption across developed and emerging healthcare systems.

Additionally, the growing geriatric population prone to joint disorders played a decisive role in shaping demand patterns in the cementless total knee systems market by fundamentally expanding the addressable surgical population. According to the World Health Organization (WHO), the global population aged 60 years and above was projected to increase from 1.1 billion in 2023 to 2.1 billion by 2050, with one in six people expected to be over 60 by 2030 and the 80+ age group projected to triple by 2060. This rapid demographic expansion substantially increased the absolute number of patients experiencing age‑related knee degeneration, stiffness, and functional decline, leading to higher procedural volumes rather than just higher incidence rates. As healthcare systems prepared for prolonged elderly independence and rising orthopedic procedure backlogs, cementless total knee systems gained importance for their ability to support long‑term joint stability and reduce the need for early revision surgeries, thereby aligning with both clinical sustainability goals and long‑term healthcare cost containment strategies.

Cementless Total Knee Systems Market Trends

Rapid technological advancements and continuous product innovation are major factors accelerating growth in the cementless total knee systems industy, as manufacturers increasingly refine implant design, surface engineering, and biologic fixation performance.

• Modern cementless fixation methods focus on achieving stable initial press‑fit and long‑term osseointegration, reducing dependency on bone cement while enhancing implant longevity. Innovations in porous coatings, additively manufactured metals, and bone‑mimicking surface architectures have significantly improved fixation reliability, making cementless systems suitable for a broader patient population, including younger, active, and cement‑sensitive patients.
• Manufacturers are increasingly leveraging 3D printing and advanced porous biomaterials to create implants that closely replicate cancellous bone structure, promoting faster and stronger bone in‑growth. Examples include Zimmer Biomet’s Trabecular Metal and Persona cementless knee systems, which use highly porous tantalum and titanium structures to support vascularization and biologic fixation, and Stryker’s Triathlon Tritanium Cementless Knee System, which integrates additively manufactured porous titanium surfaces for durable fixation and improved survivorship. These advancements have been supported by clinical and registry data demonstrating favorable mid‑ to long‑term outcomes, reinforcing surgeon confidence in cementless fixation.
• Product innovation is further driven by the integration of robotic‑assisted surgery and patient‑specific design, enabling more accurate bone preparation and implant placement to optimize cementless fixation. Johnson & Johnson’s ATTUNE AFFIXIUM Cementless Knee incorporates engineered 3D‑printed porous structures designed to enhance initial stability and long‑term bone in‑growth. These technologies, combined with improved manufacturing precision and regulatory validations, are expanding clinical indications and supporting sustained adoption of cementless total knee systems worldwide.

Cementless Total Knee Systems Market Analysis

Based on fixation method, the global cementless total knee systems market is segmented into primary fixation and hybrid fixation. The primary fixation segment accounted for a dominant market share of 59.3% in 2025, driven by its ability to deliver strong initial implant stability, reliable biological fixation, and long‑term survivorship in primary total knee arthroplasty procedures. The segment is expected to reach USD 5.8 billion by 2035, growing at a CAGR of 6.7% during the forecast period.

• Primary fixation accounted for the dominant share of the cementless total knee systems market, driven by its ability to achieve immediate implant stability through advanced press‑fit designs and biologic fixation surfaces. Increasing surgeon confidence in porous metal technologies and long‑term osseointegration outcomes strengthened adoption in primary total knee arthroplasty procedures. This fixation approach aligned well with growing demand for durable implants among younger and more active patient populations, positioning primary fixation as the preferred choice in cementless knee replacement procedures.
• The hybrid fixation segment is projected to expand at 6.3% CAGR to reach USD 3.8 billion by 2035. Hybrid fixation represented a strategic niche within the cementless total knee systems market, offering flexibility by combining cemented and cementless components to address variable bone quality across patients. This approach was particularly relevant in cases where full cementless fixation was clinically unsuitable, allowing surgeons to balance stability and fixation longevity. Although adoption remained lower than primary fixation, hybrid systems served specialized clinical needs and supported broader customization of surgical strategies.

Based on component, the cementless total knee systems market is segmented into tibial component and femoral component. The tibial component segment is projected to expand at 6.7% CAGR to reach USD 6.1 billion by 2035.

• The tibial component emerged as the dominant segment by component type, owing to its critical role in load bearing, stability, and long‑term fixation success in cementless total knee systems. Continuous advancements in porous coatings, keel designs, and 3D‑printed structures enhanced bone in‑growth and early fixation strength, driving strong clinical adoption. High revision sensitivity at the tibial interface further prioritized innovation and investment in this component, making it a key revenue contributor for manufacturers.
• The femoral component segment is projected to expand at 6.2% CAGR to reach USD 3.6 billion by 2035. The femoral component segment demonstrated steady growth, supported by improvements in anatomical contouring, surface coatings, and compatibility with cementless fixation techniques. While fixation demands were comparatively lower than the tibial side, manufacturers focused on optimizing wear characteristics and biomechanical alignment to complement cementless system performance. Adoption increased alongside integrated system designs that emphasized balanced kinematics and long‑term implant survivorship.

Based on materials, the market is segmented into metal‑on‑polyethylene, ceramic‑on‑polyethylene, and other materials. The metal‑on‑polyethylene segment is projected to expand at 6.8% CAGR to reach USD 5.4 billion by 2035.

• Metal‑on‑polyethylene dominated the cementless total knee systems market, supported by its proven clinical track record, cost‑effectiveness, and favorable long‑term performance. This material combination offered an optimal balance between mechanical strength and wear resistance, making it the preferred choice across high‑volume primary knee arthroplasty procedures. Manufacturers continued to enhance polyethylene inserts through cross‑linking and oxidation‑resistant technologies, further improving durability and reinforcing widespread surgeon preference, which sustained the segment’s leading market position.
• The ceramic‑on‑polyethylene segment is projected to expand at 6% CAGR to reach USD 3.5 billion by 2035. Ceramic‑on‑polyethylene emerged as an innovative niche segment, driven by growing interest in reduced wear, improved biocompatibility, and lower metal ion release. This material combination appealed particularly to patients with metal sensitivities and to surgeons seeking enhanced surface smoothness and long‑term articulation performance. Although adoption remained limited compared to metal‑on‑polyethylene, ongoing advancements in ceramic processing and expanding clinical evidence supported gradual uptake in select patient populations.
• The other materials segment is projected to expand at 7.1% CAGR to reach USD 803.1 million by 2035. Other materials, including hybrid and experimental composite surfaces, represented a smaller yet strategically important segment within the cementless total knee systems market. These materials were primarily explored to address specific clinical needs such as hypersensitivity, implant customization, or enhanced osseointegration. While commercial penetration remained limited, continued research and targeted innovation positioned this segment as a potential contributor to future differentiation and long‑term product development strategies.

Based on end use, the cementless total knee systems market is segmented into hospitals, orthopedic centers, and other end users. The hospitals segment dominates the market with a revenue of around USD 2.5 billion in 2025.

• Hospitals dominated the adoption of cementless total knee systems due to high surgical volumes, access to advanced operating infrastructure, and availability of specialized orthopedic surgeons. Tertiary and teaching hospitals increasingly served as early adopters of cementless technologies, driven by complex case loads and emphasis on advanced implant solutions. Centralized procurement, reimbursement coverage, and integration of robotic‑assisted surgery further reinforced hospital dominance in this market.
• The orthopedic centers segment is projected to expand at 6% CAGR to reach USD 3.8 billion by 2035. Orthopedic centers represented a fast‑growing end‑use segment, supported by increasing procedural specialization and the shift of joint replacement surgeries toward dedicated musculoskeletal facilities. These centers emphasized efficiency, standardized surgical workflows, and patient outcomes, creating favorable conditions for cementless total knee system adoption. Growth was particularly notable in private orthopedic networks and outpatient surgical facilities in developed markets.
• The other end users segment is projected to expand at 7% CAGR to reach USD 996.2 million by 2035. Other end‑use settings, including ambulatory surgical centers and specialty clinics, accounted for a smaller but emerging share of the market. Adoption in this segment was influenced by cost considerations, patient selection criteria, and procedural complexity. While penetration remained limited, the gradual expansion of outpatient knee arthroplasty programs created longer‑term growth potential for cementless systems in non‑hospital environments.

 

North America Cementless Total Knee Systems Market

The North America cementless total knee systems industry accounted for a majority share of 39.2% in 2025 and is anticipated to show notable growth over the forecast period.

• The U.S. market was valued at USD 1.6 billion and USD 1.7 billion in 2022 and 2023, respectively. The market size reached USD 1.9 billion in 2025, growing from USD 1.8 billion in 2024, and is anticipated to grow at a CAGR of 6% from 2026 to 2035.

• North America represented a leading market for cementless total knee systems, supported by high procedure volumes, advanced surgical infrastructure, and early adoption of biologic fixation technologies. Demand was driven by a large and well‑documented arthritis population, combined with increasing surgeon preference for cementless implants in younger and active patients. Strong reimbursement coverage, high penetration of robotic‑assisted surgery, and continuous product innovation by major orthopedic manufacturers further reinforced regional market maturity.
• From an epidemiological standpoint, the disease burden remained substantial. According to the U.S. Centers for Disease Control and Prevention (CDC), the prevalence of doctor‑diagnosed arthritis among U.S. adults was estimated at 21.3% in 2022, with osteoarthritis being the most common form and prevalence peaking in adults aged 75 years and older. This sustained disease load continued to translate into high demand for durable knee replacement solutions, supporting the long‑term growth outlook for cementless total knee systems.

Europe Cementless Total Knee Systems Market

Europe accounted for a significant share of the global cementless total knee systems industry and was valued at USD 1.6 billion in 2025.

• Europe exhibited strong and steady adoption of cementless total knee systems, driven by rising knee osteoarthritis prevalence, aging demographics, and an increasing focus on long‑term implant survivorship. Western and Northern European countries led procedural volumes, supported by robust public healthcare systems and standardized clinical pathways for joint replacement. European surgeons increasingly adopted cementless fixation to reduce long‑term revision risks in younger elderly populations.
• Disease prevalence significantly underpinned market demand. According to a European osteoarthritis research report published in 2022, approximately 57 million people in Western Europe were affected by osteoarthritis, with the number of cases having increased by more than 50% since 1990. Knee osteoarthritis accounted for most of the burden, reinforcing the sustained need for primary knee arthroplasty procedures and supporting the expansion of cementless total knee systems across the region.

Asia Pacific Cementless Total Knee Systems Market

The Asia Pacific market accounted for a substantial share of the market and was valued at USD 1.2 billion in 2025.

• Asia Pacific emerged as a high‑growth region for the cementless total knee systems market, supported by rapid demographic aging, rising prevalence of knee osteoarthritis, and expanding access to advanced orthopedic care. Market momentum was driven by increasing surgical volumes in countries such as Japan, China, South Korea, and Australia, where healthcare systems adapted to manage long‑term musculoskeletal conditions rather than short‑term symptom relief. Cementless fixation gained traction as surgeons increasingly prioritized implant longevity and biological fixation to address rising lifetime revision risk in patients undergoing total knee arthroplasty at relatively younger ages.
• Demographic trends significantly reinforced demand. According to UNFPA in Asia and the Pacific, the population aged over 60 years in Asia and the Pacific was expected to triple between 2010 and 2050, reaching nearly 1.3 billion people, with one in four individuals projected to be over 60 years old by 2050. This unprecedented expansion of the elderly population substantially increased the number of patients prone to degenerative joint disorders, directly contributing to higher demand for durable knee replacement solutions. As healthcare systems increasingly focused on sustaining mobility and independence among aging populations, cementless total knee systems became strategically important in supporting long‑term orthopedic outcomes across the region.

Latin America Cementless Total Knee Systems Market

The Latin American cementless total knee systems industry is anticipated to exhibit remarkable growth during the analysis period.

• Latin America emerged as a steadily expanding market for cementless total knee systems, driven by demographic aging, rising osteoarthritis burden, and gradual improvement in access to orthopedic surgical care. Urban centers across Brazil, Mexico, Argentina, and Chile increasingly adopted advanced knee replacement technologies as public and private healthcare providers expanded joint replacement capacity. Cementless fixation gained visibility as surgeons sought longer‑lasting implant solutions to address the growing volume of elderly patients undergoing primary total knee arthroplasty, particularly in private hospitals and specialty orthopedic centers.
• Demographic trends significantly reinforced market demand. According to NIH, in 2023, the Latin America and Caribbean region had an estimated 91.5 million people aged 60 years and older, representing 13.9% of the total population, and this share was projected to approach 25% by 2050. This rapid aging trajectory substantially increased the population at risk for degenerative knee disorders and functional disability. As health systems prepared for higher surgical volumes and long‑term mobility needs among older adults, cementless total knee systems became strategically relevant for supporting durable fixation, reducing revision risk, and aligning with long‑term healthcare cost and outcome objectives across the region.

Middle East and Africa Cementless Total Knee Systems Market

The Middle East and Africa market is expected to experience substantial growth over the analysis timeframe.

• The Middle East and Africa region showed emerging growth potential for cementless total knee systems, driven by gradual improvements in healthcare infrastructure, rising life expectancy, and increasing recognition of osteoarthritis as a major cause of disability. Gulf countries led regional adoption through investment in advanced orthopedic services, while adoption in Africa remained limited but steadily improving in urban tertiary care centers.
• This rising clinical load, combined with growing geriatric populations, strengthened the long‑term demand outlook for durable knee replacement solutions, including cementless total knee systems.

Cementless Total Knee Systems Market Share

• The cementless total knee systems industry is highly dynamic, with key players such as ZIMMER BIOMET, Johnson & Johnson, Smith + Nephew, Medacta, and Stryker, which collectively account for 61% share of the global market.

• In the cementless total knee systems industry, leading orthopedic manufacturers benefit from strong, long‑standing relationships with hospitals, orthopedic centers, and surgeon networks, supported by comprehensive implant portfolios and integrated procedural solutions. Their competitive strength lies in the ability to combine advanced cementless fixation technologies with preoperative planning tools, robotic‑assisted surgery compatibility, and standardized instrumentation, enabling improved surgical precision, workflow efficiency, and clinical outcomes across high‑volume joint replacement settings.
• At the same time, emerging players and regional manufacturers are gaining momentum by offering cost‑effective, anatomically optimized cementless knee systems tailored to local patient demographics and healthcare budgets. The competitive landscape is characterized by rapid innovation in porous surface engineering, 3D‑printed implants, and personalized fixation designs that enhance biological integration. Strategic collaborations, technology integrations, and targeted mergers and acquisitions remain key strategies as companies seek to expand geographic presence, broaden product portfolios, and strengthen differentiation in an increasingly competitive market.

Cementless Total Knee Systems Market Companies

A few of the prominent players operating in the global cementless total knee systems industry include:

• AESCULAP
• CONFORMIS
• Corin
• enovis
• EPISURF
• exactech
• Johnson & Johnson
• LINK
• Medacta
• MicroPort Orthopedics
• Smith +Nephew
• stryker
• symbios
• UNITED ORTHOPEDIC
• ZIMMER BIOMET

 

• ZIMMER BIOMET

Zimmer Biomet is the global leader in the cementless total knee systems market, supported by its extensive portfolio of advanced biologic fixation technologies such as Trabecular Metal and porous titanium designs. The company’s strong clinical evidence base, broad surgeon adoption, and global distribution network position it as a preferred supplier for cementless knee arthroplasty in high‑volume hospital and orthopedic center settings.

• Johnson & Johnson

Johnson & Johnson holds a strong competitive position through its cementless knee platforms incorporating 3D‑printed fixation technologies, including the ATTUNE cementless systems. Backed by Johnson & Johnson’s scale, R&D strength, and global reach, the company benefits from broad market access and increasing adoption of its cementless solutions across developed and emerging healthcare markets.

• Smith + Nephew

Smith + Nephew is a well‑established player in the cementless total knee systems market, driven by innovative offerings such as the LEGION CONCELOC system with proprietary porous structures for biological fixation. The company’s strong presence in Europe and North America, combined with continued focus on implant innovation and surgeon engagement, supports steady growth in cementless knee system adoption.

Cementless Total Knee Systems Industry News

• In October 2024, Corin announced the first clinical use of its Unity Knee MC Tibial Insert, marking a significant milestone in the field of knee replacement. This new insert is designed to improve patient outcomes with enhanced functionality and stability. The Unity Knee MC Tibial Insert is part of Corin's innovative product line that aims to address the increasing demand for high-performance knee replacement solutions.
• In November 2022, Zimmer Biomet received FDA 510(k) clearance for its Persona OsseoTi Keel Tibia, a new addition to their Persona Knee System for cementless knee replacement. This product incorporates the company's OsseoTi Porous Metal Technology, designed to mimic the structure of human bone for better biological fixation. This product launch helped the company acquire an enhanced customer base.

The global cementless total knee systems market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Fixation Method

• Primary fixation
• Hybrid fixation

Market, By Component

• Tibial component
• Femoral component

Market, By Material

• Metal‑on‑polyethylene
• Ceramic‑on‑polyethylene
• Other materials

Market, By End Use

• Hospitals
• Orthopedic centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE